How Hyperbaric Oxygen Fights Wound Infections and Antibiotic-Resistant Bacteria

Wound infections are one of the most serious complications in wound healing, and the rise of antibiotic-resistant bacteria like MRSA has made treatment increasingly challenging. Hyperbaric oxygen therapy offers a powerful weapon against wound infections by attacking bacteria through mechanisms that are fundamentally different from antibiotics. At Elite Wound Care Center in Palm Harbor, we use HBOT alongside targeted antibiotic therapy to combat even the most stubborn wound infections.

How HBOT Kills Bacteria

Hyperbaric oxygen fights wound infections through multiple pathways that work simultaneously. Many of the most dangerous wound bacteria are anaerobic, meaning they thrive in low-oxygen environments. The oxygen-poor tissue around chronic wounds creates an ideal breeding ground for these organisms. HBOT floods the wound with oxygen, creating an environment that is directly toxic to anaerobic bacteria including Clostridium species that cause gas gangrene.

Even bacteria that can tolerate oxygen are affected by HBOT. Elevated oxygen levels enhance the ability of neutrophils — the white blood cells that serve as your first line of defense against infection — to kill bacteria. Neutrophils use oxygen to produce reactive oxygen species, which are essentially chemical weapons that destroy bacterial cell walls. In low-oxygen wound tissue, neutrophil killing capacity can drop by 50% or more. HBOT restores their full killing power.

The MRSA Challenge

Methicillin-resistant Staphylococcus aureus, commonly known as MRSA, has become one of the most feared bacteria in wound care. MRSA is resistant to many common antibiotics, making infections extremely difficult to treat with medications alone. These bacteria can colonize chronic wounds and establish persistent infections that resist multiple courses of antibiotic therapy.

HBOT is particularly valuable against MRSA because its mechanisms of action are completely different from antibiotics. Bacteria cannot develop resistance to oxygen the way they develop resistance to drugs. HBOT enhances the body's own immune defenses rather than relying on chemical agents that bacteria can evolve to defeat.

Synergy with Antibiotics

Research has shown that HBOT makes certain antibiotics more effective. Some antibiotics, including aminoglycosides and fluoroquinolones, require oxygen to cross bacterial cell membranes and reach their targets inside the bacteria. In low-oxygen wound tissue, these antibiotics may not work effectively even when the bacteria are technically susceptible. HBOT restores the oxygen levels these drugs need to function properly, essentially restoring antibiotic effectiveness in tissue where they had been failing.

When to Consider HBOT for Wound Infections

HBOT should be considered when a wound infection is not responding to appropriate antibiotic therapy, when the infecting organism is resistant to available antibiotics, when the infection involves deep tissue or bone, when the wound is in an area with poor blood supply that limits antibiotic delivery, or when the patient is immunocompromised and cannot mount an adequate immune response to infection.

If you have a wound infection that is not responding to treatment, contact Elite Wound Care Center at (727) 787-7077 for an evaluation.